Neoprobe
Payments companies reported to CMS as associated with Neoprobe. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neoprobe, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neoprobe
These are the largest totals companies reported as associated with Neoprobe. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Melissa Fana | East Patchogue, NY | Surgery | $600.00 |
| Robert Lenobel | Blue Ash, OH | Diagnostic Radiology | $600.00 |
| Barry Rosen | Barrington, IL | Surgery | $556.00 |
| Brian Englander | Philadelphia, PA | Diagnostic Radiology | $556.00 |
| Kimberly Hutcherson | Lawrenceville, GA | Diagnostic Radiology | $533.14 |
| Matthew Wakefield | Greensboro, NC | Surgery | $465.00 |
| Janette Gomez | Pittsburgh, PA | Surgery | $400.00 |
| Hanadi Bu-Ali | Wauwatosa, WI | Surgery | $155.00 |
| Jean-Claude Schwartz | Statesboro, GA | Surgery | $97.14 |
| William Burak | Savannah, GA | Surgical Oncology | $96.44 |
Prescribed Neoprobe?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.